Beijing, China

Li Zhu

USPTO Granted Patents = 36 

 

Average Co-Inventor Count = 4.1

ph-index = 9

Forward Citations = 328(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2002 - 2016)
  • Burbank, CA (US) (2016 - 2019)
  • Beijing, CN (2004 - 2024)

Company Filing History:

goldMedal8 out of 33 
 
Centaurus Biopharma Co., Ltd.
 patents
silverMedal6 out of 6 
 
Genetastix Corporation
 patents
bronzeMedal6 out of 118 
 
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 patents
45 out of 18,154 
 
Boe Technology Group Co., Ltd.
 patents
55 out of 26 
 
Lianyungang Runzhong Pharmaceutical Co., Ltd.
 patents
64 out of 2,548 
 
Chengdu Boe Optoelectronics Technology Co., Ltd.
 patents
73 out of 48 
 
Adimab, LLC
 patents
83 out of 3,471 
 
Thomson Licensing
 patents
93 out of 3 
 
Primegene (beijing) Co., Ltd.
 patents
102 out of 2 
 
Institute of Biotechnology, Academy of Military Medical Sciences, China
 patents
112 out of 54 
 
Mianyang Boe Optoelectronics Technology Co., Ltd.
 patents
121 out of 23 
 
Thomas Licensing
 patents
131 out of 55 
 
Beijing Jiaotong University
 patents
141 out of 1 
 
Centaurus Biophrama Co., Ltd.
 patent
151 out of 1 
 
Chengdu Olymvax Biopharmaceuticals Inc.
 patent
161 out of 1,370 
 
Beijing Boe Technology Development Co., Ltd.
 patents
171 out of 832,843 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...
Loading Chart...
36 patents (USPTO):Explore Patents

Title: **Li Zhu: Innovator in Immunogenic Proteins and Pixel Driving Circuits**

Introduction

Li Zhu, based in Beijing, China, is a distinguished inventor with a remarkable portfolio of 31 patents to his name. His work primarily focuses on immunogenic proteins and advanced display technologies, showcasing his innovative contributions to the fields of biotechnology and electronic engineering.

Latest Patents

Among his latest inventions, Li Zhu has developed a patent for an immunogenic protein and its composition and application. This invention introduces a novel protein composed of 39 amino acids from the N-terminal α-helix region of the Ata protein transport functional domain, along with an adjuvant protein. The specific amino acid sequence derives from residues 127-165 of SEQ ID NO:2. In this endeavor, the 39 amino acids of the N-terminal α-helix of the surface protein Ata, a trimeric autotransporter, were fused with CTB and expressed in BL21. Following purification via a nickel column, the protein underwent intraperitoneal immunization in mice at a dosage of 2.5 μg/mouse. The immunogenicity and immunoprotection were substantiated through animal experiments, demonstrating efficacy in combating infections.

Additionally, Li Zhu created a remarkable patent for a pixel driving circuit and display device. This circuit comprises several interlinked components such as a data writing circuit, compensation control circuit, light emission control circuit, voltage regulation circuit, and a driving transistor. It showcases advanced functionalities that allow stable voltage maintenance and efficient light emission control in display technologies.

Career Highlights

Over the years, Li Zhu has contributed his expertise to reputable companies, including Centaurus Biopharma Co., Ltd. and Genetastix Corporation. His innovative research has significantly pushed the boundaries in his fields of specialization, leading to valuable patents that advance technology and medicine.

Collaborations

Throughout his career, Li Zhu has collaborated with notable peers, including Shaobing Benjamin Hua and Yongxin Han. These professional partnerships have fostered new ideas and breakthroughs in their respective fields, reflecting the essence of collaborative innovation.

Conclusion

Li Zhu stands out as an innovative force, with a strong portfolio that includes cutting-edge advancements in immunogenic proteins and pixel driving technologies. His ongoing work not only contributes to medical science but also enhances electronic display systems, establishing him as a pivotal figure in contemporary invention and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…